Business
US biotech Novavax could make COVID vaccine onshore in Australia – Sydney Morning Herald
The company behind Australia’s third major coronavirus vaccine candidate says it would be happy to set up shop in Australia, just like its competitor Moderna.
American biotechnology company Novavax has outlined plans to make doses of its coronavirus vaccine in Australia after revealing it is searching for a manufacturing partner to produce its protein-based jab onshore.
The federal government has ordered 51 million doses of Novavaxs product, which is still awaiting regulatory clearances in the US and Australia. In an interview with The Sydney Morning Herald and The Age, Novavaxs chief commercial officer John Trizzino said the company has had early conversations…
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General18 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business9 hours agoFord CEO makes stunning prediction about artificial intelligence